BML Capital Management’s Carisma Therapeutics CARM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-411,398	Closed	-$1.28M	–	33
2023 Q1	$1.28M	Hold	411,398	–	–	1.1%	21
2022 Q4	$5.01M	Buy	+411,398	New	+$5.01M	4.79%	9